A Different Path to Relief?: The Left Atrium to Coronary Sinus Shunt for Heart Failure
- PMID: 37316148
- DOI: 10.1016/j.jcin.2023.04.014
A Different Path to Relief?: The Left Atrium to Coronary Sinus Shunt for Heart Failure
Keywords: coronary sinus; heart failure; heart failure with preserved ejection fraction; pulmonary vascular resistance.
Conflict of interest statement
Funding Support and Author Disclosures Dr Borlaug has received research support from the National Institutes of Health and the United States Department of Defense; has received research grant funding from AstraZeneca, Axon, Medtronic, Novo Nordisk, Rivus, and Tenax Therapeutics; has served as a consultant for Actelion, Amgen, Aria, Axon Therapies, BD, Boehringer Ingelheim, Cytokinetics, Edwards Lifesciences, Eli Lilly, Imbria, Janssen, Merck, Novo Nordisk, NGM, NXT, and VADovations; and is the named inventor (US patent number 10,307,179) for the tools and approach for a minimally invasive pericardial modification procedure to treat heart failure. Dr Borlaug is supported in part by National Institutes of Health grants (R01 HL128526 and U01 HL160226) and the U.S. Department of Defense (W81XWH2210245). Dr Alkhouli has reported that he has no relationships to the contents of this paper to disclose.
Comment on
- 
  
  Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure.JACC Cardiovasc Interv. 2023 Jun 12;16(11):1369-1380. doi: 10.1016/j.jcin.2023.03.012. Epub 2023 Mar 21. JACC Cardiovasc Interv. 2023. PMID: 36989271
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
 
        